The Philadelphia Flyers have announced an extension of their partnership with NexGen Hyperbaric for the 2025–26 season. NexGen Hyperbaric is recognized for its hyperbaric oxygen therapy technology, and its proprietary mobile unit system will continue to be available at Flyers’ facilities. This system is described as the only platform of its kind in the country.
The agreement ensures that Flyers athletes can access advanced recovery treatments on-site, which are tailored to meet the physical demands of professional hockey. The partnership also extends benefits to former players through the Flyers Alumni program, offering them continued medical and wellness support.
Ian McKeown, Vice President of Athlete Performance & Wellness for the Philadelphia Flyers, stated: “Our partnership with NexGen Hyperbaric has become an invaluable part of our player care and wellness strategy. By extending this relationship, we ensure that both our current roster and our Alumni can continue to benefit from NexGen’s innovation and advanced medical technology.”
Jonathan Rotella, President & CEO of NexGen Hyperbaric, said: “We are honored to extend our partnership with the Philadelphia Flyers. Working alongside the Flyers’ outstanding physicians and clinicians, our mission is to deliver the most advanced, evidence-based hyperbaric medicine available, and to support the health, performance, and recovery of the Flyers organization and its distinguished Alumni.”
The organization says it remains focused on providing high-quality health resources for both current athletes and alumni through this ongoing collaboration.
